Biomedical Engineering Reference
In-Depth Information
32. Perin EC et al (2003) Transendocardial, autologous bone marrow cell transplantation for
severe, chronic ischemic heart failure. Circulation 107:2294-2302
33. Taylor DA et al (1998) Regenerating functional myocardium: improved performance after
skeletal myoblast transplantation. Nat Med 4:929-933
34. Hutcheson KA et al (2000) Comparison of benefits on myocardial performance of cellular
cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant 9:359-368
35. Thompson RB et al (2003) Comparison of intracardiac cell transplantation: autologous skel-
etal myoblasts versus bone marrow cells. Circulation 108(suppl 1):II264-II271
36. Balsam LB et al (2004) Haematopoietic stem cells adopt mature haematopoietic fates in
ischaemic myocardium. Nature 428:668-673
37. Murry CE et al (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myo-
cytes in myocardial infarcts. Nature 428:664-668
38. Nygren JM et al (2004) Bone marrow-derived hematopoietic cells generate cardiomyocytes
at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10:494-501
39. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM et al (2006) Cytokine-mediated
deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangio-
cytes. Nat Med 12(5):557-67. Erratum in: Nat Med 12(8):978
40. Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood endothelial progenitor cells
are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation
107:1164-1169
41. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S et al (2004) Marrow-derived
stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote
in vitro and in vivo arteriogenesis through paracrine mechanism. Circ Res 94:678-685
42. Zhang S, Zhang P, Guo J, Jia Z, Ma K, Liu Y et al (2004) Enhanced cytoprotection and angio-
genesis by bone marrow cell transplantation may contribute to improved ischemic myocar-
dial function. Eur J Cardiothorac Surg 25:188-195
43. Hirata K, Li TS, Nishida M, Ito H, Matsuzaki M, Kasaoka S, Hamano K (2002) Autologous
bone marrow cell implantation as therapeutic angiogenesis for ischeminc hindlimb in dia-
betic rat model. Am J Physiol Heart Circ Physiol 28(1):H66-H70
44. Adams BG, Scadden DT (2006) The hematopoietic stem cells in its place. Nat Immunol
7:333-337
45. Adams BG, Chabner KT, Alley JR, Scadden D et al (2006) Stem cell engraftment at the
endosteal niche is specified by the calcium-sesning receptor. Nat Lett 439:599-603.
doi:
10.1038/nature0424
46. Wojakowski W, Tendera M, Michalowska A, Majka M, Kucia M, Ratajczak MZ et al (2004)
Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells
expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients
with acute myocardial infarction. Circulation (Genetics) 110:3213-3220
47. Kucia M, Dawn B, Hunt G, Guo Y, Wysoczynski M, Majka M et al (2004) Cells expressing
early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood
after myocardial infarction. Circulation Res 95(12):1191-1199
48. Kucia M, Reca R, Jala V, Dawn B, Ratajczak J, Ratajczak MZ (2005) Bone marrow as home
of heterogeneous populations of nonhematopoietic stem cells. Leukemia 19:1118-1127
49. Kucia M, Ratajczak J, Ratajczak ZM (2005) Bone marrow as a source of circulating CXR4+
tissue-commited stem cells. Biol Cell 97:133-146
50. Kucia M, Ratajczak J, Ratjczak MX (2005) Are bone marrow cells plastic or heterogeneous-
that is the question. Exp Hematol 33(6):613-623
51. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, Ratajczak MZ (2006) Embryonic
stemcell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizon-
tal transfer of mRNA and protein delivery. Leukemia 20:847-856
52. Kucia M, Wojakowski W, Ryan R, Machalinski B, Gozdzik J, Majka M, Baran J, Ratajczak
J, Ratjczak MZ (2006) The migration of bone marrow-derived non-hematopoietic tissue-
commited stem cells is regulated in and SDF-1-, HGF-, and LIF dependent manner. Arch
Immunol Ther Exp 54(2):121-135
